Deutsche Bank’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-620
Closed -$46K 4310
2020
Q1
$46K Sell
620
-286
-32% -$19.8K ﹤0.01% 3583
2019
Q4
$58K Hold
906
﹤0.01% 3897
2019
Q3
$57K Hold
906
﹤0.01% 3862
2019
Q2
$61K Buy
906
+670
+284% +$44.1K ﹤0.01% 4431
2019
Q1
$15K Sell
236
-104
-31% -$6.91K ﹤0.01% 4843
2018
Q4
$21K Sell
340
-2,278
-87% -$159K ﹤0.01% 4724
2018
Q3
$202K Sell
2,618
-2,597
-50% -$196K ﹤0.01% 4237
2018
Q2
$369K Buy
5,215
+3,250
+165% +$230K ﹤0.01% 3998
2018
Q1
$147K Sell
1,965
-1,380
-41% -$110K ﹤0.01% 4336
2017
Q4
$239K Buy
3,345
+37
+1% +$2.81K ﹤0.01% 3951
2017
Q3
$267K Sell
3,308
-3,520
-52% -$269K ﹤0.01% 3731
2017
Q2
$482K Buy
6,828
+3,795
+125% +$253K ﹤0.01% 3472
2017
Q1
$205K Buy
3,033
+2,031
+203% +$143K ﹤0.01% 3580
2016
Q4
$70K Sell
1,002
-3,453
-78% -$257K ﹤0.01% 4234
2016
Q3
$352K Buy
4,455
+4,081
+1,091% +$332K ﹤0.01% 3364
2016
Q2
$31K Sell
374
-677
-64% -$60.1K ﹤0.01% 4606
2016
Q1
$96K Sell
1,051
-3,848
-79% -$347K ﹤0.01% 4040
2015
Q4
$495K Buy
4,899
+1,126
+30% +$117K ﹤0.01% 3277
2015
Q3
$370K Buy
3,773
+2,713
+256% +$301K ﹤0.01% 3524
2015
Q2
$124K Sell
1,060
-700
-40% -$76.5K ﹤0.01% 4124
2015
Q1
$172K Sell
1,760
-3,890
-69% -$395K ﹤0.01% 3858
2014
Q4
$532K Buy
5,650
+4,000
+242% +$414K ﹤0.01% 3630
2014
Q3
$175K Sell
1,650
-450
-21% -$44.1K ﹤0.01% 4156
2014
Q2
$174K Buy
2,100
+600
+40% +$46.7K ﹤0.01% 4222
2014
Q1
$2K Sell
1,500
-6,109
-80% -$479K ﹤0.01% 5347
2013
Q4
$226K Sell
7,609
-227
-3% -$15.8K ﹤0.01% 3631
2013
Q3
$151K Buy
7,836
+896
+13% +$53.5K ﹤0.01% 4256
2013
Q2
$93K Buy
+6,940
New +$362K ﹤0.01% 4262

Other funds holding GILD

Deutsche Bank's GILD Position: Q1 2026 in Review

Deutsche Bank increased its Gilead Sciences (GILD) stake by 0.46% in Q1 2026, buying an estimated $4M and bringing the position to 6,222,328 shares worth $867M. The position accounts for 0.29% of the portfolio, ranked #71.

Deutsche Bank first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.16B in Q4 2015. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Deutsche Bank held 6,222,328 shares of Gilead Sciences worth $867M as of Q1 2026.
  • Deutsche Bank bought 28,574 Gilead Sciences shares in Q1 2026, an estimated $4M.
  • Gilead Sciences made up 0.29% of Deutsche Bank's portfolio in Q1 2026, its #71 holding.
  • Deutsche Bank first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • Deutsche Bank's Gilead Sciences position peaked at $1.16B in Q4 2015.
  • 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.